BEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Franklin Resources Inc (BEN) is not an ideal buy for a beginner investor with a long-term strategy and $50,000-$100,000 available at this time. While the company has shown strong financial performance in its latest quarter and has some positive developments in private market solutions, the stock's technical indicators are neutral, options sentiment is bearish, and analyst ratings are mixed with a generally cautious outlook. Additionally, the lack of significant trading trends and no recent congress trading data further support a hold recommendation.
The MACD is positive but contracting, RSI is neutral at 49.8, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock has a 70% chance of declining by -1.56% in the next week and -9.65% in the next month, which suggests potential downside risk in the near term.
Strong financial performance in 2026/Q1 with revenue up 5.26% YoY, net income up 61.47% YoY, and EPS up 58.62% YoY.
Franklin Templeton's private equity strategy surpassing $3.5 billion in assets under management.
Partnership with Binance to launch an institutional off-exchange collateral program, addressing demand for stable assets.
Mixed analyst ratings with some firms maintaining Underweight or Underperform ratings and price targets below the current price.
Stock trend analysis suggests a high probability of short-term and medium-term price declines.
No significant hedge fund or insider trading trends, indicating limited confidence from key stakeholders.
In 2026/Q1, Franklin Resources reported strong growth: Revenue increased by 5.26% YoY to $2.437 billion, net income surged by 61.47% YoY to $239.3 million, EPS rose by 58.62% YoY to $0.46, and gross margin improved by 4.81% YoY to 36.84%.
Analyst ratings are mixed. Morgan Stanley and Barclays maintain Underweight ratings with price targets of $22, while TD Cowen is incrementally bullish with a Hold rating and a price target of $36. BofA has an Underperform rating with a price target of $21. The overall sentiment suggests caution, with some analysts seeing limited upside.
